In preclinical literature, the terminal plasma half-life of Melanotan 1 ranges from 30 to 60 minutes, though its receptor occupancy and downstream signaling persist longer in cell models. PX1 Research supplies high-purity [Melanotan 1 10mg vials](/product/mti-melanotan1-10mg) backed by USA synthesis, lot-specific HPLC/MS and endotoxin COAs, and same-day shipping from CA and AZ facilities.
In preclinical literature, the terminal plasma half-life of Melanotan 1 ranges from 30 to 60 minutes, though its receptor occupancy and downstream signaling persist longer in cell models. PX1 Research supplies high-purity [Melanotan 1 10mg vials](/product/mti-melanotan1-10mg) backed by USA synthesis, lot-specific HPLC/MS and endotoxin COAs, and same-day shipping from CA and AZ facilities.
In vitro and animal model data indicate that Melanotan 1 (afamelanotide) exhibits a rapid plasma elimination half-life typical of short-chain linear peptide analogs. In mammalian plasma assays, the peptide demonstrates a elimination half-life between 30 and 60 minutes due to rapid enzymatic cleavage and renal clearance. However, its biological activity—specifically its high affinity for the melanocortin-1 receptor (MC1R)—results in receptor activation and intracellular signaling that outlasts the presence of intact peptide in solution.
Unlike cyclic melanocortins or lipidated peptide constructs, Melanotan 1 does not utilize fatty-acid acylation or Drug Affinity Complex (DAC) technology to prolong circulation. Consequently, in vitro assay protocols measuring cAMP accumulation or melanogenesis typically structure exposure windows around this early half-life window. Researchers requiring verified reference material can access fully characterized research peptides with complete analytical documentation directly through PX1 Research.
When designing experiments involving melanocortin signaling, understanding these metabolic parameters ensures precise dosing schedules, accurate wash-out timing, and repeatable analytical data across cellular models.
Melanotan 1, often designated in scientific literature as mt1 or afamelanotide, is a synthetic peptide analog of the endogenous alpha-melanocyte-stimulating hormone (α-MSH). Chemically structured as [Nle4, D-Phe7]-α-MSH, this 13-amino-acid linear peptide was specifically engineered to enhance resistance to rapid proteolytic degradation compared to native α-MSH. In laboratory settings, mt1 serves as a primary tool for investigating melanocortin receptor activation, pigmentary pathways, and cutaneous photoprotection mechanisms.
The primary mechanism of action for melanotan i centers on its potent, non-selective agonist activity at melanocortin receptors, with highest selective potency observed at MC1R. Binding of the peptide to MC1R stimulates adenylate cyclase, raising intracellular cyclic adenosine monophosphate (cAMP) levels. Preclinical studies suggest that this cascade upregulates microphthalmia-associated transcription factor (MITF) and tyrosinase expression, driving the enzymatic production of eumelanin in melanocyte cell cultures.
Because of its key role as a standard reference compound in melanocortin receptor pharmacology, researchers require highly consistent material. Laboratories looking to investigate these pathways can purchase reference-grade Melanotan 1 10mg featuring verified sequence integrity and batch-to-batch uniformity.
Pharmacokinetic evaluations across rodent, canine, and non-human primate models consistently establish the systemic plasma half-life of Melanotan 1 within the 30-to-60-minute window following parenteral administration. Following IV or subcutaneous bolus administration in animal models, plasma concentration levels decay rapidly during the alpha clearance phase, followed by a brief beta elimination phase.
Despite this relatively short intravascular residence time, animal models show that the biological half-life—defined by receptor occupancy, persistent cAMP stimulation, and downstream gene expression—extends significantly beyond initial systemic clearance. MC1R activation in cultured human melanocytes demonstrates sustained receptor internalization and prolonged signaling cascades even after brief 15-to-30-minute exposure windows.
For investigators modeling pharmacokinetic/pharmacodynamic (PK/PD) relationships, distinguishing between physical compound elimination and duration of biological effect is critical. Precise cell culture wash-out steps must account for the rapid initial clearance phase while measuring long-term downstream cellular responses.
The metabolic fate and half-life of melanotan i are governed by its specific molecular architecture, enzymatic susceptibility, and primary elimination pathways. Understanding these biochemical properties provides insight into why the peptide behaves differently from native α-MSH and cyclic melanocortin analogs.
The molecular weight of Melanotan 1 is approximately 1646.85 g/mol. Native α-MSH is subject to instant cleavage by serum endopeptidases, dipeptidyl peptidase IV (DPP-4), and neutral endopeptidases (NEP). To mitigate this, Melanotan 1 incorporates two strategic modifications: substitution of Met4 with Norleucine (Nle4) and L-Phe7 with D-Phenylalanine (D-Phe7). The D-Phe7 substitution creates steric hindrance at the central His-Phe-Arg-Trp core motif, significantly retarding cleavage by endopeptidases.
Despite these structural protections, Melanotan 1 remains a linear peptide lacking cyclic stabilization or carrier protein conjugation (such as albumin binding via acylation). Consequently, glomerular filtration in the kidneys accounts for a substantial portion of rapid peptide elimination. Furthermore, exopeptidases gradually cleave the N-terminal and C-terminal residues in systemic circulation, leading to its observed 30-to-60-minute clearance profile.
In cell culture environments, peptide stability differs from live systemic clearance because renal filtration and dynamic organ clearance are absent. However, thermal degradation and enzymatic degradation by cell-secreted proteases in serum-supplemented media still dictate effective exposure times.
For acute signaling assays, such as measuring intracellular cAMP accumulation or receptor phosphorylation, peak signal generation typically occurs within 15 to 45 minutes of peptide introduction. Standard protocols often utilize an initial incubation window of 30 minutes, after which cells are lysed or washed to prevent receptor desensitization or downregulation.
For long-term assays evaluating melanosome maturation, tyrosinase activity, or cell proliferation over 24 to 72 hours, culture media containing the peptide is typically refreshed every 12 to 24 hours. This replenishment schedule compensates for peptide breakdown in culture media maintained at 37°C. Researchers interested in broader receptor cross-talk may also compare these kinetics against other melanocortin pathway research compounds in our catalogs.
When selecting melanocortin receptor agonists for comparative research, researchers frequently evaluate Melanotan 1 alongside native ligands and alternative synthetic constructs like Melanotan 2 and PT-141 (Bremelanotide). Clearance kinetics and structural differences play a central role in experimental selection.
Melanotan 2 is a cyclic heptapeptide lactam analog. Due to its rigid, cyclic structure, Melanotan 2 exhibits higher resistance to enzymatic cleavage and demonstrates a slightly extended plasma half-life (approximately 1 to 2 hours in preclinical models) compared to the linear structure of Melanotan 1. Furthermore, Melanotan 2 displays broader non-selective receptor binding across MC3R, MC4R, and MC5R, whereas Melanotan 1 remains predominantly focused on MC1R pathways.
Similarly, PT-141 (Bremelanotide) is a cyclic metabolite derivative designed for selective central nervous system melanocortin receptor studies. Native α-MSH possesses the shortest half-life of all, rapidly degrading within minutes in uninhibited plasma. When designing comparative binding assays, scientists choose order 10 mg vials of Retatrutide or melanocortin reagents depending on whether linear or cyclic peptide stability is required for their specific analytical platform.
To ensure reproducible data in preclinical research, obtaining verified, high-purity peptides is essential. Impurities, trifluoroacetate (TFA) salt residues, or endotoxin contamination can confound cell culture assays and alter observed receptor binding kinetics.
Laboratories evaluating vendors for melanocortin research compounds should demand rigid analytical verification before purchase. Below is the standardized evaluation matrix used by leading academic and institutional buyers:
1. Purity Verification: Every lot must undergo high-performance liquid chromatography (HPLC) demonstrating ≥98.0% purity, accompanied by mass spectrometry (MS) confirming exact molecular weight (1646.85 g/mol). 2. Endotoxin Testing: Quantitative chromogenic LAL assays must confirm endotoxin levels below <0.5 EU/mg, preventing cell culture toxicity or artifactual inflammatory signaling. 3. Lot Traceability: Vendors must maintain distinct COAs for every individual synthesis batch rather than displaying static example certificates. 4. Sourcing Transparency: Peptide synthesis, lyophylization, and quality control processing should occur in ISO 9001 certified facilities under strict atmospheric control. 5. Logistics and Cold-Chain: Lyophilized peptides must ship rapidly from domestic fulfillment centers to minimize ambient temperature exposure prior to laboratory storage. 6. Institutional Support: Direct access to responsive technical support staffed by knowledgeable specialists capable of addressing analytical questions.
The market for research peptides contains significant variability in vendor quality. Purchasing from unvetted sources risks compromised experimental integrity due to under-dosed vials, degraded sequences, or heavy microbial contamination.
A primary red flag is any vendor providing a generic, un-dated Certificate of Analysis (COA) without matching lot numbers on the physical vial label. Static COAs often mask batch-to-batch variation or hide the presence of truncated peptide impurities resulting from inefficient solid-phase peptide synthesis (SPPS).
Another major red flag is any supplier offering dosing calculators, reconstituted storage advice for human use, or therapeutic health claims. Such practices violate regulatory standards and typically indicate a non-compliant retail vendor lacking proper laboratory-grade quality controls. To review compliant, fully documented compounds, visit our dedicated research guide library.
Finally, avoid vendors that fail to provide mass spectrometry data confirming exact peptide identity. Without mass spec verification, high HPLC purity peaks can easily hide incorrect sequence isomers or incomplete peptide fragments.
PX1 Research operates as a dedicated USA-based supplier of high-purity research peptides, catering directly to university laboratories, contract research organizations (CROs), and independent scientific investigators. Our supply chain is built around absolute analytical transparency and rapid domestic fulfillment.
Every lot of Melanotan 1 10mg undergoes rigorous third-party analytical testing prior to release. We verify purity (≥98.0% via HPLC), exact molecular weight (via ESI-MS), and biological safety (<0.5 EU/mg endotoxin). These reports are published directly on our lot-verification portal, giving researchers immediate access to raw analytical data.
By maintaining state-of-the-art fulfillment facilities in California and Arizona, PX1 Research eliminates international customs delays and ensures swift, temperature-monitored transit across the United States. Institutional buyers seeking bulk allocations can also access specialized volume terms through our wholesale peptide program.
When you order Melanotan 1 from PX1 Research, you receive vacuum-sealed, lyophilized glass vials designed for optimal long-term stability. Vials are packaged with tamper-evident caps and labeled with lot-specific tracking codes that link directly to your batch's Certificate of Analysis.
We process and dispatch all orders placed before 2:00 PM MST Monday through Friday on the same business day. Shipments originate from our CA or AZ fulfillment hubs, utilizing fast, fully tracked domestic express shipping options to ensure your materials arrive intact and without unnecessary exposure to ambient heat.
To review full analytical specifications, inspect current batch COAs, or complete an institutional procurement order, visit our official product page to buy Melanotan 1 10mg vials today.
Is Melanotan 1 legal to buy in the US?
Yes, Melanotan 1 is legal to purchase in the United States strictly as a scientific research chemical intended for laboratory, in vitro, and preclinical research. It is not approved for human or veterinary use, medical treatment, or cosmetic application.
What is the reported half-life of Melanotan 1 in preclinical models?
In animal pharmacokinetic studies, Melanotan 1 exhibits a plasma elimination half-life of approximately 30 to 60 minutes. However, its biological half-life—measured by MC1R occupancy and intracellular cAMP downstream activation—persists significantly longer in cell culture models.
How fast does PX1 Research ship Melanotan 1 orders?
PX1 Research ships all orders placed before 2:00 PM MST Monday through Friday on the exact same day. Shipments dispatch from our California and Arizona fulfillment centers via tracked domestic shipping to minimize transit time.
Do you provide a COA for my specific lot of Melanotan 1?
Yes, PX1 Research provides a lot-specific Certificate of Analysis for every batch. Each COA includes HPLC purity analysis (≥98%), mass spectrometry identity verification, and quantitative endotoxin testing (<0.5 EU/mg).
What purity level is guaranteed for mt1 from PX1 Research?
All mt1 supplied by PX1 Research is guaranteed to meet or exceed 98.0% chemical purity as measured by High-Performance Liquid Chromatography (HPLC) with mass spectrometry sequence verification.
How does the half-life of melanotan i compare to Melanotan 2?
Melanotan 1 is a linear peptide with a plasma half-life of 30–60 minutes, whereas Melanotan 2 is a cyclic peptide structure. Cyclic structures generally offer higher enzymatic stability, giving Melanotan 2 a slightly longer plasma elimination window (1–2 hours).
How should lyophilized Melanotan 1 be stored upon delivery?
Lyophilized Melanotan 1 should be stored in a dry, dark freezer environment at -20°C for long-term stability. Upon reconstitution in suitable laboratory buffers, liquid aliquots should be kept refrigerated at 2–8°C and used within experimental timelines.
Can I purchase Melanotan 1 in bulk for institutional research?
Yes, institutional buyers and CROs requiring larger quantities or continuous lot allocations can request high-volume fulfillment through the PX1 Research wholesale program.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.